Report Date: November 15, 2026|Scope: Global exchange groups, central counterparties (CCPs) and securities depository/settlement infrastructure (excluding securities brokerage)|Industry View: Cautiously Bullish (12–24 months)
One-Line Conclusion: 2025 was a record year for volume and price across the industry (US options +26%, US equities ADV +44.6%, HKEX ADT +90%); in 2026 trading demand has begun an uneven decline (US equities ADT -17.6% YoY in October 2026, HKEX October ADT roughly -27%), but the US Treasury mandatory clearing regime (cash effective 2026-12-31, repo 2026-06-30... note: repo effective 2027-06-30) and data/index recurring revenue (renewal price increases of ~10%) provide structural growth that can hedge the decline; the revenue pool of the five major operators is projected to grow from ~$31.0 billion in 2025 to ~$35.2 billion in 2027 (base case, ~+6.6% CAGR). The industry's business quality is the best in financials (EBITDA margins 50–70%, FCF conversion ~98%, zero credit leverage), but static P/E ratios of 24–42x already price in substantial record-year earnings—returns are more likely to take the form of an "earnings plateau + valuation digestion." Position in clearing and index/data segments; avoid pure cash-equity match-making.
This industry is the "toll road + utilities" of global capital markets: trade match-making (cash and derivatives), central counterparty clearing (listed and OTC), depository settlement (CSD), market data distribution and index licensing. A one-line map of the value chain: Issuers (listing fees) → Investors/market makers/members (trading and clearing fees) → Data users and asset managers (subscription and index licensing fees). Clearing and data capture the fattest margins due to regulatory mandates and network effects, while cash-equity match-making is the thinnest due to off-exchange diversion and fee caps.
Research coverage: listed operators CME Group, Intercontinental Exchange (ICE), Cboe, Nasdaq, Deutsche Börse, London Stock Exchange Group (LSEG), HKEX, MSCI (index-side extension); unlisted infrastructure DTCC/FICC, Euroclear, OCC, LCH (LSEG-controlled) are included as competitive-landscape variables. Securities brokerage and market makers' own economics are out of scope.
Volume elasticity to volatility is strong and two-sided: in April 2025's tariff-shock month, CME ADV hit a record 35.9 million contracts (+27.8% vs. the full-year average), and single-day US options exceeded 100 million contracts on April 4; as volatility subsided in 2026, US equities ADT fell -17.6% YoY (October 2026, SIFMA). The rates path is the second-largest variable: the Fed's effective federal funds rate at 3.88% (2026-11-12), the September dot-plot median implying another hike to 4.1% within the year, and divergent re-tightening among the three major central banks are pushing up SOFR/Euribor/TONA curve volatility, directly amplifying rates derivatives and swap-clearing demand. Retail penetration is structural: 0DTE accounts for 24.1% of US options volume (21.5% in 2024), a record 66.2% of SPX single-contract volume as of July 2026, Micro E-mini volume +35%; 58% of US households own equities. Passive capital is the growth engine of index licensing.
After counter-evidence adjustments (trading fees priced on a combination of "volume +12% × per-contract rate -3%"; Treasury clearing rates at the mid-point of competitive discounts), the five drivers total roughly +$4.2 billion/year: trading fees +$1.41 billion (rate-mix erosion included), Treasury mandatory clearing +$1.0 billion (range $0.56–1.48 billion, see D2), data and index +$1.4 billion, IPO listing fees +$0.4 billion; corresponding to the five-operator revenue pool growing from $31.0 billion to ~$35.2 billion (+6.6%/year). If neither volume nor price deteriorates (bull-case assumption), the original demand bridge would be +$5.27 billion/year, implying ~$36.3 billion in 2027.
This industry has no physical capacity constraint: matching is software scaling with near-infinite elasticity; CME's 2025 free cash flow of $4.19 billion was ~98% of operating cash flow, with capex under $100 million. The real supply constraints are three: ① Clearing-side capital lock-up—global IRS CCP initial margin of $358 billion and top-10 listed-derivatives CCP margin of $613 billion (2025Q4, +22%); the margin spiral itself constitutes a capital threshold to "capacity"; ② Operational resilience—three CME outages within 12 months (2025-11 Thanksgiving CyrusOne data-center cooling failure halting Globex for over half a day; 2026-02 metals and natural gas suspension); the Google Cloud migration has been pushed to end-2027, and operational incidents are becoming a potential decisive factor in share reallocation; ③ Liquidity cold start—licenses are not the bottleneck (MEMX, IEX, LTSE and TXSE all received SEC approval; TXSE opened on 2026-07-10); the bottleneck is the cold start of liquidity and listing networks: LTSE share near zero, MEMX options share only 3.8%.
Products (CME prediction/event contracts and 24/7 crypto futures/options launched in 2026; credit, mortgage and power contracts scaling up); sessions (NYSE Arca and Nasdaq 23×5 overnight sessions launched 2026-12-06, CME crypto already 7×24); cross-border and cross-asset (HKEX OTC Clear margin balance $2.1 billion, +34%, Swap Connect scaling; LCH Listed Rates taking FMX futures clearing); platforms (DTCC securities tokenization pilot completed on-chain validation in July 2026; Euroclear/Clearstream euro-bond digital issuance phased in from 2026; DLT-issued securities eligible as Eurosystem collateral from 2026-03-30).
US futures commission merchants (FCMs) fell from a 2005 peak of 190 to 63 at end-2023 and 71 in March 2026, of which only 24 provide swap client clearing; LCH SwapClear direct clearing members at 62 (2025Q3, down from a peak of 69); DTCC GSD's top-5 clearing members account for 73.3% of client transactions (2025Q4). Clearing-member shrinkage raises access and porting risk: a default of the top-5 clearing members would require porting 15.1% of SwapClear's and 21% of ICC's client portfolios within days. Large bank members, by virtue of scale, hold real bargaining power over fees and margin models (rebates and discounts are common), but liquidity network effects mean fee concessions cannot buy migration—this is the industry's most counterintuitive bargaining-power structure.
Extreme capital lightness: CME's 2025 dividends of ~$3.74 billion (~104% of that year's FCF) plus a $3 billion buyback authorization; ICE 2025 shareholder returns of $2.4 billion (57.3% of adjusted FCF); HKEX payout ratio 90% (2024–2025); Cboe has the lowest return intensity (dividends at 16.9% of FCF). CCPs' own risk capital is small: CME's guaranty fund requirement is $2.65 billion + $150 million company contribution; systemic buffers rest mainly on member funds—the company level has zero credit leverage while systemic risk is concentrated (see I8 Risks).
① Administered pricing + monopoly clearing: CME revenue per contract (RPC) ~$0.707 in 2025, falling to $0.679 in 2026Q3 (-3%, micro-contract and product-mix dilution); OCC options clearing fee $0.025/contract (a counter-cyclical 25% hike approved by the SEC in December 2024—explicit pricing power from monopoly clearing with no substitute); Cboe SPX market-maker fees $0.23–0.28/contract, exclusive license already extended to 2051. ② Regulatory caps: US cash-equity access fee cap cut from $0.003 to $0.001 per share (compliance by 2027-11), plus maker-taker rebates—net exchange cash-equity take rates near zero, two decades of deflation. ③ Subscription and licensing: market data renewal price increases of ~10% vs. buy-side data budget growth of +4.1% (the scissors gap = real pricing power); index licensing charges bps on AUM plus per-contract options licensing fees.
CME revenue can be decomposed as ADV×RPC: 28.1 million contracts × 252 days × $0.707 ≈ $5.01 billion, roughly 94% of disclosed clearing & transaction fees (the difference being BrokerTec/EBS and OTC clearing). Operating leverage is extremely high: CME 2026Q3 incremental operating profit/incremental revenue = 84.5% (77.1% for the first nine months); cost growth (9M'26 expenses +6.2%) is systematically below revenue growth (+9.3%). Float income is a hidden profit item: CME's total investment income for the first nine months of 2026 was $4.237 billion (against ~$155.2 billion of client margin balances), of which 89.1% was returned to clearing members and $635 million retained (~15% of pre-tax profit)—a -100bp move in rates would drag CME EPS by ~4%; the bulk of the float belongs to members, not shareholders.
Base path: sector revenue pool of ~$33.0 billion in 2026 and ~$35.2 billion in 2027; CME 2026E adjusted EPS ~$12.2–12.4 (9M'26 EPS +13.1%); HKEX 2026E net profit ~HK$19.58 billion (first nine months +15%), turning negative YoY from H1 2027 (high base); DB1, LSEG and MSCI recurring growth (+7–13%) forms the earnings floor. Normalization test (assuming 2027 volumes revert to 2024 levels): CME net profit only -8% (normalized P/E ~26x vs. current static 28.4x); Cboe roughly -13% (normalized ~30x vs. static 36.2x); HKEX net profit -24% (back to the actual 2024 figure of HK$13.05 billion, normalized P/E ~32x rather than the superficial TTM 24.3x), with a drawdown exceeding -35% if southbound liquidity overshoots and reverses. Conclusion: record-year earnings depress static P/E by 3–8 points—an "valuation illusion"; the cheapness of pure volume-beta names (HKEX, Cboe) is illusory, while CME/MSCI's premium is supported by recurring revenue.
Benchmark-contract migration has failed every time in history: Eurex's USD IRS managed only 4.3%, ELX failed to dent CME Treasury futures, HKEX's MSCI China A50 failed to dent SGX's FTSE A50; the only successful redistributions were regulator-driven (India's GIFT Nifty migration, EU EMIR 3.0 active-account requirements giving Eurex a 5.1% share in euro rates swaps, fully applicable from 2026-12-12). But three new competitive fronts have emerged this cycle: ① FMX (backed by Citadel and other market makers) launched SOFR futures in 2024-09, expanded to 2Y/5Y Treasury futures in 2025 with clearing by LCH Listed Rates—directly dismantling "clearing bundling," a core CME moat; ② ICE, via Polymarket, proposes DLT-collateral 24/7 clearing, challenging the CCP business model itself; ③ prediction markets are diverting event-speculation demand on the retail side. The monopoly conclusion stands, but the defense cost of marginal rents is rising (corroborated by CME's RPC -3% mix erosion).
The derivatives trading + clearing net-fee pool is ~$18–20 billion/year (2025 estimate: CME $6.5B + ICE exchanges $5.4B + Cboe ~$2.3B + Eurex ~$1.8B + APAC $1.5–2.0B), EBITDA margin 55–70%; the market data pool of $49.2 billion (+6.5%) and index pool of $7.2 billion (+13.4%) are growing faster with higher margins (MSCI gross margin 82.4%). Migration direction is clear: profit is shifting from "per-contract trading fees" to "recurring revenue"—Deutsche Börse's recurring share has reached 63%, and the growth ranking of index > data > trading fees is established; cash-equity matching (52% off-exchange + fee caps) is the donor. Note the counter-evidence: within MSCI's recurring revenue, quarterly recurring subscription growth (+$44.5 million) has fallen below AUM-linked fee growth (+25%)—"recurring = zero beta" does not hold; index providers are "low volume-beta, high AUM-beta."
| Company | Positioning | Scale/Profitability | Valuation | One-Line Take |
|---|---|---|---|---|
| CME | Rate/energy/agri benchmark derivatives + integrated clearing | FY25 revenue USD 6.52bn (+6.4%), EBITDA margin 69.9%, FCF USD 4.19bn | Static 28.4x, normalized ~26x | The purest global "rate volatility option"; under receding volume beta, normalized drawdown only -8%, highest cyclical floor |
| ICE | Energy benchmarks (Brent/TTF) + NYSE + data + mortgage tech | FY25 net revenue USD 9.9bn (+7%) | Static 30.8x | Most balanced multi-engine; mortgage tech carries rate-cycle exposure, Polymarket is an option-style bet |
| Cboe | SPX/VIX exclusivity (through 2051) + data | FY25 net revenue ~USD 2.3bn (+17%), adjusted EPS USD 10.67 (+24%) | Static 36.2x, normalized ~30x | Quasi-index-provider monopoly quality, but record 0DTE volume + 36x static = timing risk |
| Nasdaq | Cash equities matching + listings + indices + Adenza fintech | FY25 net revenue USD 5.2bn, Solutions 77% of total | Static 34.8x | Transformation template: from matchmaker to software vendor, valuation partly priced in |
| Deutsche Börse | Euro rate benchmark + clearing + custody + indices full chain | FY25 net revenue ~EUR 5.6bn (+9%), recurring 63% | Not available | Biggest EMIR 3.0 beneficiary: first regulation-driven market share redistribution in years |
| LSEG | Data (ex-Refinitiv) + FTSE indices + LCH clearing | FY25 revenue ~GBP 9.0bn, EBITDA margin 50.3% | Not available | The LCH + FTSE dual-monopoly assets are worth far more than London cash equities |
| HKEX | Hong Kong sole operator + offshore China risk pricing | FY25 net profit HKD 17.75bn, ROE 31.7%, payout 90% | TTM 24.3x (2nd percentile of 5 years), normalized ~32x | The "cheap" percentile is compressed by record earnings; largest earnings beta in the sector |
| MSCI | Pure index licensing + subscriptions | FY25 revenue USD 3.13bn (+9.7%), gross margin 82.4% | Static 41.9x | Textbook "monopoly + rent collection," but contains AUM beta rather than zero beta |
There is no unified global exchange-sector index; the core 8 names trade at static P/E of 24–42x, with a midpoint of ~30–32x (FY2025 EPS × 2026-11-13 close). HKEX is the only stock where a percentile can be computed: P/E (TTM) of 24.3x sits at the 2nd percentile of 5 years, P/B of 8.59x at the 51st percentile — but that percentile uses record earnings as the denominator and must be re-read on normalized earnings (~32x). US leaders are near 52-week highs; CME has underperformed the sector ETF year-to-date since reporting record revenue in 2026Q3 — the market has begun voting on "record earnings are unsustainable." A-shares have no listed exchange stocks and SW has no corresponding industry index, so sector-level valuation percentiles are not available and will not be speculated upon. Boom-vs-valuation verdict: the boom persists (revenue pool +6.6%/yr) but is not overheated; valuations price cyclical-peak earnings — the conclusion is "harvest the earnings, guard against the valuation."
US market structure: The Rule 605 amendment (execution-quality disclosure) took effect 2026-08-01, marginally positive for exchange transparency; tick size USD 0.005 + access fee cap of 0.1 cents upheld by courts, compliance by 2027-11 (institutional suppression on cash take rates); Rule 615 competitive auctions not yet implemented, under review (would be a major positive if enacted); SEC has withdrawn 14 proposals from the prior term (incl. PFOF ban, mandatory SBS clearing) — regulation shifting to light touch. 23×5 overnight sessions launch 2026-12-06. Clearing policy (biggest variable): US Treasury mandatory clearing takes effect for cash on 2026-12-31 and repo on 2027-06-30 — but it has already been delayed once, the SEC clarified exclusion of ~USD 1tn of mixed-collateral trades, and SIFMA's expanded affiliated-entity exemption is pending; ~58% of in-scope repo (per OFR) is already cleared, so incremental volume is smaller than the headline penetration gap. In the EU, EMIR 3.0's active-account requirement applies from 2026-12-12 = quasi-position policy, shifting euro rate clearing share to Eurex; MiFIR revisions (open access + consolidated tape) apply in stages from 2026-03, with the EuroCTP equity tape confirmed and the derivatives tape awarded — a structural dilution of European data rents. Monetary policy: the Fed's September dot plot median implies hikes to 4.1% within the year, the ECB may hike again in December to 2.75%, the BoJ at 1.25% and rising — three central banks tightening simultaneously = rate volatility dividend + thicker margin balance interest income, directionally positive. Geopolitics: US-China delisting risk centers on "proactive relocations" rather than forced delistings (87 new HKEX listings in 2026H1 raising HKD 210.2bn, second globally); fragmentation raises the number of venues and clearing nodes overall and deepens licensing moats — moderately positive for infrastructure. Net direction: positive — clearing mandates and the rate volatility dividend outweigh fee caps and European data-tape dilution; internal ranking: clearinghouses > rate derivatives hubs > pure cash matching venues.
Bulls: 0DTE at 66% of SPX volume and still penetrating; retail options-ization and Micro contracts (+50%) are structural behavioral shifts; options ADV still +12% in Jan–Oct 2026; CME 9M'26 revenue +9.3%. Bears: retail short-dated gamma is a crowded trade, not a moat; the 2025 pulses of +26%/+44.6% have reversed in 2026 (US equities ADT -17.6%, HKEX Jan–Oct only +2.2%); CME's -3% per-contract rate shows volume up, price down. Metrics to track: monthly OCC/FIA volumes, whether CME RPC stays below USD 0.70 for two consecutive quarters, 0DTE share changes, southbound net flows.
Bulls: rules are set (cash 2026-12-31, repo 2027-06-30); CME has SEC clearing-agency registration (planned launch 2026-12-07); FICC hit a record USD 13.9tn in a single day; ~80% of member account structures are ready; penetration going from 50% to 85% implies ~USD 3.7tn/day of new cleared notional. Bears: this is the sector's most brutally contested arena — FICC's member model prices near cost; CME cross-margins futures-cash (extended to clients on 2026-04-30) as implicit bundling concessions; ICE is approved to enter with no capital-offset advantage and can only grab share on price; if fees fall from the assumed USD 1.6 per million to USD 0.8, the USD 1.48bn/yr increment is halved to USD 740m. Metrics to track: FICC/ICE fee schedule changes, whether CME folds cash Treasury clearing into futures bundling, SEC exemption decisions, quarterly penetration data.
Bulls: the scissors gap of data renewals +10% vs. buyer budgets +4.1%; SPX exclusivity to 2051; a 100% failure rate in benchmark-contract migration history; passive flows' rigidity. Bears: the UK FCA and the EU are replacing the data negotiation table with a regulatory one (free/low-cost consolidated tape); EMIR 3.0 proves regulation can force share redistribution; FMX + LCH are dismantling CME's clearing bundle; ICE-Polymarket's DLT clearing and prediction markets siphon retail; MSCI's recurring subscription growth is converging toward buyer budgets. Metrics to track: EuroCTP tape rollout pace, FMX SOFR futures volume and LCH Listed Rates margin balances, MSCI quarterly subscription adds, CME event-contract fee disclosures.
Monthly tracking: FIA/OCC/SIFMA volume data (D1); quarterly tracking: operators' RPC and recurring disclosures (D1/D3), Treasury clearing penetration (D2).
Upper right, "Core allocation": CME (rates + clearing hub, smallest normalized drawdown), MSCI/index licensing (82% gross margin, AUM-linked compounding), Cboe (SPX exclusivity to 2051, but valuation prices in record volume — a tactical position). Lower right, "Value trap": US cash equities matching — volume boom persists, but 52.1% of flow is off-exchange, fee caps pushed to USD 0.001/share, and rebates erode net capture to near zero — a classic "volume up, profit thin" boom illusion; a bullish boom view ≠ worth buying — paying for the right segment matters more than paying for the right direction. Upper left, "high quality but declining boom": HKEX — monopoly quality and the 90% payout are real, but ADT has downshifted (October ~-27%) with the sector's largest earnings beta; normalized P/E of ~32x is not cheap — wait for confirmation of an ADT plateau before entering.
Beneficiaries: ① CME — rate volatility + clearing hub, normalized EPS drawdown only -8%, 26x normalized P/E is the sector's most stable vehicle for "harvesting earnings"; ② MSCI and the index segment — passive-ization structural dividend + 82% gross margin, mind the AUM beta; ③ Deutsche Börse — recurring 63% + the regulatory dividend of EMIR 3.0 euro share repatriation; ④ LSEG — LCH monopoly + data price hikes, EBITDA margin 50.3% and rising; ⑤ ICE — energy benchmarks + data + mortgage tech multi-engine, with Polymarket offering option-style upside. Avoid/caution: pure US cash matching (including new entrants' matching businesses); the timing risk of buying Cboe's record volume at 36x static P/E (quality fine, price not); Nasdaq's transformation premium (34.8x static vs. Solutions growth). Watch: HKEX (quality + dividends real, waiting for a volume plateau); prediction markets (Kalshi/Polymarket, 400%+ growth but unproven profit model and jurisdiction; incumbents respond via co-optation).
| Scenario | Biggest beneficiaries | Biggest losers |
|---|---|---|
| Bear (30%) | MSCI, LSEG (recurring and pricing power as ballast, lowest volume-beta exposure) | HKEX (net profit -24%~-35% + normalized 32x), Cboe (-13% + 36x static) |
| Base (50%) | CME, Deutsche Börse (clearing increment + regulatory dividend delivered) | US cash matching segment, Nasdaq legacy trading lines |
| Bull (20%) | CME (ADV 30m+ contracts), ICE (clearing + Polymarket double hit) | New entrant matching venues (TXSE/MEMX, liquidity flowing back to incumbent benchmarks) |
① Sharper-than-expected volume mean reversion (retail 0DTE crowded trade collapsing after a volatility event); ② Treasury mandatory clearing price war and further scope shrinkage (increment halved at USD 0.8/million fees); ③ regulatory erosion of data/index rents (European consolidated tape free/low-cost, EMIR 3.0 model spreading to dollar clearing); ④ systemic: mandatory clearing concentrates rate risk in CCPs — if the first major clearing-member default resolution occurs after 2027 compliance, it would be a sector-level event (zero credit leverage at the company level ≠ zero systemic risk); ⑤ operational accidents (CME's three outages in 12 months, delayed cloud migration) accelerating share redistribution; ⑥ capital-allocation inefficiency of buybacks at the cyclical top (CME executing at ~104% of FCF returned at a 26–30x record-earnings level).
Data sources: FIA, WFE, SIFMA, ISDA, Burton-Taylor, Clarus (CCPView), SEC/CFTC/ESMA/European Commission, US Treasury TBAC, OCC, DTCC, Euroclear, and company disclosures (see citation list). Key estimates (revenue pool, normalized earnings, clearing increment) are proprietary; methodologies and assumptions are flagged in the text.